Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Tetracycline

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44343   clinical trials with a EudraCT protocol, of which   7372   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    Study title: Trachoma therapy with topical tetracycline and oral erythromycin: a comparative trial. Dawson C R, Daghfous T, Hoshiwara I, Ramdhane K, Kamoun M, Yoneda C, Schachter J. Bulletin of the World Health Organization, {Bull−World−Health−Organ}, 1982, vol. 60, no. 3, p. 347−55.
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26534
    Study title: Treatment of chlamydial urethritis in men and Chlamydia trachomatis− positive female partners: comparison of erythromycin and tetracycline in treatment courses of one week. Scheibel J H, Kristensen J K, Hentzer B, Secher L, Ullman S, Verdich J, Weismann K. Sexually transmitted diseases, {Sex−Transm−Dis}, Jul−Sep 1982, vol. 9, no. 3, p. 128−31.
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26533
    Study title: A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children. Roy S K, Islam A, Ali R, Islam K E, Khan R A, Ara S H, Saifuddin N M, Fuchs G J. Transactions of the Royal Society of Tropical Medicine and Hygiene, Jul Aug 1998, vol. 92, no. 4, p. 460 2.
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26446
    Study title: A Single Blind Comparative Study of Doxycycline 50 mg Daily versus Oxytetracycline 500 mg Twice Daily in the Management of Inflammatory Acne Vulgaris
    Active substance: DOXYCYCLINE
    Study summary document link (including results): DXC-UK-85-001121 EMA Pediatrics Web Synopsis.pdf
    View full study record
    Document reference: 48023
    Study title: Clinical and bacteriological evaluation of tetracycline and erythromycin in acne vulgaris. Al Mishari M A. Clinical therapeutics, {Clin−Ther}, 1987, vol. 9, no. 3, p. 273−80, ISSN: 0149−2918.
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26511
    Study title: Comparative trial of erythromycin and sulphatrimethoprim in the treatment of tetracycline−resistant Vibrio cholerae O1. Burans JP, Podgore J, Mansour MM, Farah AH, Abbas S, Abu Elyazeed R, Woody JN. Transactions of the Royal Society of Tropical Medicine and Hygiene, Nov−Dec 1989, vol. 83, no. 6, p. 836−8.
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26497
    Study title: Comparative trial of erythromycin and tetracycline in common infections found in general practice.Gomez J R, Gomez G. The British journal of clinical practice, {Br−J−Clin−Pract}, 11 Nov 1968, vol. 22, no. 11, p. 475−7,
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26561
    Study title: Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma. Fraser-Hurt N, Bailey RL, Cousens S, Mabey D, Faal H, Mabey DC. Bull World Health Organ. 2001;79(7):632-40.
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26568
    Study title: Khimioterapevticheskaia éffektivnost' eritromitsina, rifampitsina i tetratsiklinov pri khlamidioze I mikoplasmoze u detei. (Chemotherapeutic effectiveness of erythromycin, rifampicin and tetracyclines in chlamydiosis and mycoplasmosis in children). Vasilos LV, Rumel NB, Shchuka SS. Antibiotiki i khimioterapiiÍa = Antibiotics and chemoterapy (sic) / Ministerstvo meditsinskoi I mikrobiologicheskoi promyshlennosti SSSR, Jun 1995, vol. 40, no. 6, p. 40−2.
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26460
    Study title: A MASS TREATMENT TRIAL FOR CONTROL OF TRACHOMA. THAKOR VH, RANA ST. Bull World Health Organ. 1963;29835-7
    Active substance: CHLORTETRACYCLINE
    Study summary document link (including results): A MASS TREATMENT TRIAL FOR CONTROL OF TRACHOMA. THAKOR VH, RANA ST. Bull World Health Organ. 1963;29835-7.pdf
    View full study record
    Document reference: 24079
    Study title: Report of 4 years' follow-up of a trachoma clinical trial in Taiwan. Assaad FA, Maxwell-Lyons F, Sundaresan T. Bull World Health Organ. 1968;38(4):565-76. Report of 4 years' follow-up of a trachoma clinical trial in Taiwan. Assaad FA, Maxwell-Lyons F, Sundaresan T. Bull World Health Organ. 1968;38(4):565-76.
    Active substance: CHLORTETRACYCLINE
    Study summary document link (including results): Report of 4 years' follow-up of a trachoma clinical trial in Taiwan. Assaad FA, Maxwell-Lyons F, Sundaresan T. Bull World Health .pdf
    View full study record
    Document reference: 24080
    Study title: A randomized clinical trial of two topical preparations (framycitin/gramicidin and oxytetracycline/hydrocortisone with polymyxin B) in the treatment of external otitis. Wadsten CJ, Bertilsson CA, Sieradzki H, EdstrÃm S. Arch Otorhinolaryngol. 1985;242(2):135-9. A randomized clinical trial of two topical preparations (framycitin/gramicidin and oxytetracycline/hydrocortisone with polymyxin B) in the treatment of external otitis. Wadsten CJ, Bertilsson CA, Sieradzki H, EdstrÃm S. Arch Otorhinolaryngol. 1985;242(2):135-9.
    Active substance: CIPROFLOXACIN HYDROCORTIZONE
    Study summary document link (including results):
    View full study record
    Document reference: 24290
    Study title: TO COMPARE DOXYCYCLINE 50 MG WITH OXYTETRACYCLINE 250 MG BID IN THE TREATMENT OF INFLAMMATORY ACNE VULGARIS.
    Active substance: FLUCONAZOLE
    Study summary document link (including results):
    View full study record
    Document reference: 27335
    Study title: A randomized clinical trial of two topical preparations (framycitin/gramicidin and oxytetracycline/hydrocortisone with polymyxin B) in the treatment of external otitis. Wadsten CJ, Bertilsson CA, Sieradzki H, Edström S. Arch Otorhinolaryngol. 1985;242(2):135-9.
    Active substance: FRAMYCETIN
    Study summary document link (including results): A randomized clinical trial of two topical preparations.pdf
    View full study record
    Document reference: 28623
    Study title: Strömqvist B. Femoral head vitality after intracapsular hip fracture. 490 cases studied by intravital tetracycline labeling and Tc-MDP radionuclide imaging. Acta Orthop Scand Suppl. 1983;200:1-71. No abstract available. Strömqvist B. Femoral head vitality after intracapsular hip fracture. 490 cases studied by intravital tetracycline labeling and Tc-MDP radionuclide imaging. Acta Orthop Scand Suppl. 1983;200:1-71. No abstract available.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44059
    Study title: Treatment of trachoma in the West Bank. Chumbley LC, Viswalingam ND, Thomson IM, Zeidan MA. Eye. 1988;2 ( Pt 5):471-5.Treatment of trachoma in the West Bank. Chumbley LC, Viswalingam ND, Thomson IM, Zeidan MA. Eye. 1988;2 ( Pt 5):471-5.
    Active substance: OXYTETRACYCLINE
    Study summary document link (including results): Treatment of trachoma in the West Bank. Chumbley LC, Viswalingam ND, Thomson IM, Zeidan MA. Eye. 1988;2 ( Pt 5)471-5.pdf
    View full study record
    Document reference: 33043
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Jun 15 23:49:15 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA